Login / Signup

Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease.

Marta FreitasTiago Lima CapelaVítor Macedo SilvaCátia ArieiraTiago Cúrdia GonçalvesFrancisca Dias de CastroMaria João MoreiraJoão Firmino-MachadoJosé Cotter
Published in: Pancreas (2022)
Although AIP was a relatively common adverse effect, it presented a mild course in all patients. Smoking, concomitant use of budesonide, and single-dose regimen of AZA should be avoided in IBD patients treated with AZA.
Keyphrases